Elsayed G.E. Elsakka

1.6k total citations
38 papers, 1.3k citations indexed

About

Elsayed G.E. Elsakka is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Elsayed G.E. Elsakka has authored 38 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 24 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Elsayed G.E. Elsakka's work include MicroRNA in disease regulation (24 papers), Circular RNAs in diseases (17 papers) and Cancer-related molecular mechanisms research (13 papers). Elsayed G.E. Elsakka is often cited by papers focused on MicroRNA in disease regulation (24 papers), Circular RNAs in diseases (17 papers) and Cancer-related molecular mechanisms research (13 papers). Elsayed G.E. Elsakka collaborates with scholars based in Egypt, Saudi Arabia and Japan. Elsayed G.E. Elsakka's co-authors include Ahmed S. Doghish, Hesham A. El‐Mahdy, Ahmed Ismail, Ahmed I. Abulsoud, Samy Y. Elkhawaga, Nourhan M. Abdelmaksoud, Ahmed A. El-Husseiny, Maghawry Hegazy, Mahmoud Mohamed Mokhtar and Doaa Fathi and has published in prestigious journals such as Neuroscience & Biobehavioral Reviews, Experimental Cell Research and Life Sciences.

In The Last Decade

Elsayed G.E. Elsakka

38 papers receiving 1.3k citations

Peers

Elsayed G.E. Elsakka
Elsayed G.E. Elsakka
Citations per year, relative to Elsayed G.E. Elsakka Elsayed G.E. Elsakka (= 1×) peers Hesham A. El‐Mahdy

Countries citing papers authored by Elsayed G.E. Elsakka

Since Specialization
Citations

This map shows the geographic impact of Elsayed G.E. Elsakka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elsayed G.E. Elsakka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elsayed G.E. Elsakka more than expected).

Fields of papers citing papers by Elsayed G.E. Elsakka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elsayed G.E. Elsakka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elsayed G.E. Elsakka. The network helps show where Elsayed G.E. Elsakka may publish in the future.

Co-authorship network of co-authors of Elsayed G.E. Elsakka

This figure shows the co-authorship network connecting the top 25 collaborators of Elsayed G.E. Elsakka. A scholar is included among the top collaborators of Elsayed G.E. Elsakka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elsayed G.E. Elsakka. Elsayed G.E. Elsakka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abulsoud, Ahmed I., Sherif S. Abdel Mageed, Alaa Ashraf, et al.. (2025). The Role of MicroRNAs in Neurodegeneration: Insights from Huntington’s Disease. Molecular Neurobiology. 62(7). 8502–8517. 2 indexed citations
2.
El‐Sayyad, Gharieb S., Ahmed I. Abulsoud, Mohamed Hemdan, et al.. (2025). The role of miRNAs in pathogenesis, diagnosis, and therapy of Helicobacter pylori infection, gastric cancer-causing bacteria: Special highlights on nanotechnology-based therapy. Microbial Pathogenesis. 205. 107646–107646. 1 indexed citations
3.
Saleh, Lobna A., et al.. (2024). Agmatine alleviates diabetic-induced hyposalivation in rats: A histological and biochemical study. Life Sciences. 359. 123220–123220. 1 indexed citations
4.
Elsakka, Elsayed G.E., Ahmed I. Abulsoud, Shereen Saeid Elshaer, et al.. (2024). The miRNA Landscape in Crohn's disease: Implications for novel therapeutic approaches and interactions with Existing therapies. Experimental Cell Research. 442(2). 114234–114234. 1 indexed citations
5.
Yehia, Amr Mohamed, Elsayed G.E. Elsakka, Ahmed I. Abulsoud, et al.. (2023). miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma. Pathology - Research and Practice. 248. 154704–154704. 25 indexed citations
6.
Elshaer, Shereen Saeid, Ahmed I. Abulsoud, Doaa Fathi, et al.. (2023). miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay. Pathology - Research and Practice. 246. 154511–154511. 55 indexed citations
7.
Hegazy, Maghawry, Mohamed A. Elkady, Amr Mohamed Yehia, et al.. (2023). The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay. Pathology - Research and Practice. 246. 154510–154510. 45 indexed citations
8.
Doghish, Ahmed S., Maghawry Hegazy, Ahmed Ismail, et al.. (2023). A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance. Pathology - Research and Practice. 245. 154442–154442. 49 indexed citations
9.
Elkhawaga, Samy Y., Ahmed Ismail, Elsayed G.E. Elsakka, et al.. (2023). miRNAs as cornerstones in adipogenesis and obesity. Life Sciences. 315. 121382–121382. 67 indexed citations
10.
Doghish, Ahmed S., Ahmed A. El-Husseiny, Nourhan M. Abdelmaksoud, et al.. (2023). The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer. Pathology - Research and Practice. 246. 154529–154529. 40 indexed citations
11.
Mahdy, Hazem A., Hazem Elkady, Mohammed S. Taghour, et al.. (2023). New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations. Future Medicinal Chemistry. 15(14). 1233–1250. 24 indexed citations
12.
El-Husseiny, Ahmed A., Nourhan M. Abdelmaksoud, Sherif S. Abdel Mageed, et al.. (2023). miRNAs orchestration of salivary gland cancer- Particular emphasis on diagnosis, progression, and drug resistance. Pathology - Research and Practice. 248. 154590–154590. 34 indexed citations
13.
Elsakka, Elsayed G.E., Ahmed I. Abulsoud, Hesham A. El‐Mahdy, et al.. (2023). miRNAs orchestration of cardiovascular diseases – Particular emphasis on diagnosis, and progression. Pathology - Research and Practice. 248. 154613–154613. 30 indexed citations
14.
El‐Mahdy, Hesham A., Ahmed M. Mohamadin, Ahmed I. Abulsoud, et al.. (2023). miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses. Pathology - Research and Practice. 245. 154457–154457. 47 indexed citations
15.
Doghish, Ahmed S., Ahmed I. Abulsoud, Shereen Saeid Elshaer, et al.. (2023). miRNAs as cornerstones in chronic lymphocytic leukemia pathogenesis and therapeutic resistance– An emphasis on the interaction of signaling pathways. Pathology - Research and Practice. 243. 154363–154363. 53 indexed citations
16.
El‐Mahdy, Hesham A., Elsayed G.E. Elsakka, Ahmed A. El-Husseiny, et al.. (2023). miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay – A review. Pathology - Research and Practice. 242. 154316–154316. 57 indexed citations
17.
Allam, Shady, Elsayed G.E. Elsakka, Ahmed Ismail, et al.. (2023). Androgen receptor blockade by flutamide down-regulates renal fibrosis, inflammation, and apoptosis pathways in male rats. Life Sciences. 323. 121697–121697. 38 indexed citations
18.
Abd‐Allah, Gamil M., Ahmed Ismail, Hesham A. El‐Mahdy, et al.. (2023). miRNAs as potential game-changers in melanoma: A comprehensive review. Pathology - Research and Practice. 244. 154424–154424. 52 indexed citations
19.
Ismail, Ahmed, Ahmed I. Abulsoud, Doaa Fathi, et al.. (2022). The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay. Pathology - Research and Practice. 240. 154222–154222. 55 indexed citations
20.
Doghish, Ahmed S., Ahmed Ismail, Hesham A. El‐Mahdy, et al.. (2022). miRNAs insights into rheumatoid arthritis: Favorable and detrimental aspects of key performers. Life Sciences. 314. 121321–121321. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026